Mark Petersen
Head of Global Services, Omnichannel Execution Boehringer IngelheimDay 1 | 20th October
1:40 PM Case Study: From Optichannel to Outcomes: How to fix fragmented journeys to increase HCP conversion
- Why is pharma's focus on omnichannel and optichannel potentially reinforcing outdated, channel-first thinking rather than improving HCP engagement?
- What does the reality of optichannel look like inside organisations, and why do fragmented journeys and activity-based KPIs still persist?
- How can leaders move away from channel optimisation toward truly customer-centric engagement models that prioritise outcomes over activity?
- As AI-driven engagement accelerates, could manual channel selection become obsolete, and where should pharma leaders be investing instead?
Day 2 | 21th October
2:35 PM Crystal Ball Fireside Chat & Polling: What is the future of pharma engagement: hype, hope or hard reality?
AI promises transformation, omnichannel promises scale, and data promises insight, but what will truly change pharma engagement over the next ten years? This crystal-ball segment takes a visionary look ahead at what the future for pharma sector in an AI-driven world.
Join leaders as they:
- Examine how AI, omnichannel, CRM and customer expectations will reshape pharma engagement and what pharma needs to prioritise now to stay ahead.
- Discover which technologies will move from experimentation to business-as-usual
- Discuss what will disappear, what will scale, and what will remain stubbornly unchanged
- Where pharma leaders should invest now, and where to hold back
Check out the incredible speaker line-up to see who will be joining Mark.
Download The Latest Agenda